Abstract
The systemic mycoses form a group of diseases which are difficult to diagnose and treat. They attack the human organism, selecting sometimes the lung tissue as in coccidioidomycosis, in histoplasmosis etc., or spread through the blood stream attacking the central nervous system, the gastrointestinal tract, the circulatory system, the eyes, the bones, the joints, the skin, provoking fatal consequences for the patient, as in systemic candidiasis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Lutz A (1908) Una mycose pseudococcidica localizada na boca e observada no Brasil. Contribuiçao ao estudo das hyphoblastomycoses americanas. Brasil-méd 22:121–124/141-144.
Paracoccidioidomycosis — Proceedings of the First Pan American Symposium (1972) Scientific Publication 254, Pan American Health Organization, Washington.
Negroni P (1966) El Paracoccidioides brasiliensis vive saprofiticamente en el suelo argentino. Prensa-med argent 53:2381–2382.
Albornoz MB (1971) Isolation of Paracoccidioides brasiliensis from rural soil in Venezuela. Sabourandia 9:248–253.
Grose E, Tamsitt JR (1965) Paracoccidioides brasiliensis recovered from the intestinal tract of three bats (Artibeus lituratus) in Colombia S.A. Sabouraudia 4:124–125.
Johnson WD, Lang CM (1977) Paracoccidioidomycosis (South American blastomycosis) in a squirrel monkey (Saimiri sciureus). Vet Path 14:363–371.
Naiff RD, Ferreira LCL, Barrett TV, Naiff MF, Arias JR (1986) Paracoccidioidomicose enzoôtica em tatus (Dasypus novemcinctus) no Estado do Para. Rev Inst Med Trop São Paulo 28:19–27.
Fava Netto C, Martins-Castro R, Padilha-Gonçalves A, Dillon NL (1965) Ocorrência familiar da blastomicose sul-americana. Rev Inst Med Trop São Paulo 7:332–336.
Gonzalez-Ochoa A (1956) Classificatión clinica de las micosis. Rev Inst Salubr Enf Trop (Mex) 16:1–8.
Moraes, CR, Fiorillo AM, Costa JC (1967) Lesões radiológicas intestinais na blastomicose sul-americana. Hospital (Rio de Janeiro) 71:733–744.
Fonseca LC, Mignone C (1976) Paracoccidioidomicose do intestino delgado. Aspectos anatomoclinicos e radiológicos de 125 casos. Rev Hosp Clin Fac Med S. Paulo 31:199–207.
Martinez R, Meneghelli VG, Dantas RO, Fiorillo AM (1979) O comprometimento gastrintestinal na blastomicose sul-americana (paracoccidioidomicose). I. Estudo clinico, radiológico e histopatológico. Rev Ass Med Brasil 25:31–34.
Brito T, Carvalho RPS, Martins Castro R, Furtado JS (1972) Pathogenesis of experimental Paracoccidioidomycosis. Paracoccidioidomycosis, Proc First Pan Am Symposium Scientific Pub 254, PAHO, Washington, pp 257–260.
Grimaldi de Jimenez G, Yegres F, San-Blás F (1979) Liberation of protoplasts from the yeast-like form of Paracoccidioides brasiliensis by enzymatic treatment. Sabouraudia 17:279–285.
Teixeira GA, Machado Filho J, Miranda JL (1985) Blastomicose sul-americana experimental. Estudo experimental em ratos com considerações relativas à patogenia das lesões. Hospital (Rio de Janeiro) 68:1018–1096.
Padilha-Gonçalves A (1964) Sub-clinical adenopathy in Lutz mycosis. First congress of the international society of tropical dermatology, Nápoles, June, 8–13, 1964. Minerva Dermat 39 (suppl 1):32.
Padilha-Gonçalves A (1971) Adenopatia da micose de Lutz. Thesis to be Titular Professor of Dermatology, Rio de Janeiro, Copicentro-Rio.
Lacaz CS (1956) South American blastomycosis. An Fac Med Univ S. Paulo 29:2–120.
Fava Netto C (1976) Imunologica da paracoccidioidomicose. Rev Inst Med Trop São Paulo 18:42–53.
Yarzábal LA (1971) Anticuerpos precipitantes especĂficos de la blastomicosis sudamericana revelados por immunoelectroforesis. Rev Inst Med Trop Säo Paulo 13:320–327.
Yarzábal LA, Andrieu S, Bout D, Naquira F (1976) Isolation of a specific antigen with alkaline phosphatase activity from soluble extracts of Paracoccidioides brasiliensis. Sabouraudia 14:275–280.
Puccia R, Schenkman S, Gorin PAJ, Travassos RL (1986) Exocellular components of Paracoccidioides brasiliensis: identification of a specific antigen. Infect Immun 53:199–206.
San-Blás G, San-Blás F, Serrano LE (1979) Host-parasite relationship in the yeast-like form of Paracoccidioides brasiliensis strain IVIC Pb9. Infect Immun 15:343–346.
Scroferneker ML, Fava Netto C, Schalch ALO (1983) Contribuiçao para o estudo da composiçao antigênica do Paracoccidioides brasiliensis. Anais do II Encontro sobre Paracoccidioidomicose, Botucatu, p 1.
Orsi S, Biagioni L, Sadatsune T Franco M (1983) Caracterização imunolôgica de amostras de P. brasiliensis isolades de pacientes de área endêmica de Botucatu. July 21–23, Botucatu, P2.
Padilha-Gonçalves A (1985) Paracoccidioidomicose. Atualidade. Classificação. An brasil dermatol 60 (supl l):271–280.
Ajello L, Kaufman L, Kaplan W, George L (1962) Laboratory manual for medical mycology. Communicable Disease Center, Atlanta, Georgia.
Alsip S, Dismukes WE (1986) Approach to the patient with suspected histoplasmosis. In: Remington JS, Swartz MN (eds) Current clinical topics in infectious diseases. MacGraw-Hill, New York, pp 254–296.
Arechavala A, Negroni (1978) Estado inmunitario de enfermos portadores de micosis sistemicas. Rev Arg Micol 1 (3):5–11.
Borelli D (1970) Prevalence of systemic mycosis in Latin América. In: International symposium on mycoses. PAIIO Scient Publ 205:28–38.
Conant NF, Smith DT, Baker RD et al. (1971) Manual of clinical mycology, 3rd edn. Saunders, London.
Chandler FW, Kaplan W, Ajello L (1980) A colour atlas and text book of the histopathology of mycotic diseases. Wolfe Medical, Lochern, The Netherlands.
Emmons ChW, Binford Ch, Utz JP (1977) Medical mycology. Lea and Febiger, Philadelphia.
Goodwin R, Loyd JE, Des Prez R (1981) Histoplasmosis in normal host. Medicine 60 (4):231–266.
Goodwin RA, Shapiro JL et al. (1984) Disseminated histoplasmosis. Clinical and pathologic correlations. Medicine 59:1–33.
Larsh HW (1970) Ecology and epidemiology of histoplasmosis. Proc Intern Symp Mycoses. Pan Am Health Org 59-63.
Negroni P (1960) Micosis profundas, vol II Histoplasmosis, ComisiĂłn de Investigaciones CientĂficas de la Provincia de Buenos Aires.
Negroni R (1978) Manifestaciones cutáneas de 1a histoplasmosis. Rev Arg Micol 1 (1):5–16.
Negroni R (1976) InmunologĂa de las micosis sistĂ©micas. Rev Asoc Arg Microb 8:117–127.
Negroni R (1980) Ketoconazole in the treatment of paracoccidioidomycosis and histoplasmosis. Vth Intern conf mycoses. Scientific Publication No 396. Pan Am Health Org.
Rubinstein P, Negroni R (1981) Micosis broncopulmonares del adulto y del niño, 2nd edn. Editorial Beta, S.R. Buenos Aires.
Sarosi GA, Davies SF (1982) Clinical manifestations and management of histoplasmosis in compromised patient. In: Warnock DIW, Richardson MD (eds) Fungal infection in the compromised patient, Wiley, Chichester, Chap. 7, pp 187–198.
Sarosi G, Davies SF (1984) Histoplasmosis. En Braude A. Enfermedades Infecciosas. Editorial Panamericana. Buenos Aires, pp 217–223.
Slam ThG (1983) Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole. Am J Med 78:70–73.
Dismukes WE, Stamm AM, Graybill JR et al. (1983) Treatment of systemic mycoses with ketoconazole: emphasis on toxicity and clinical response in 52 patients. Ann Int Med 98:13–20.
McManus EJ, Jones JM (1986) The use of ketoconazole in the treatment of blastomycosis. Am Rev Resp Dis 133:141–143.
Bradsher RW, Rice DC, Abernathy RS (1985) Ketoconazole therapy for blastomycosis. Ann Int Med 103:872–879.
NIAID Mycoses Study Group (1985) Treatment of blastomycosis and histoplasmosis with ketoconazole. Ann Int Med 103:861–872.
Dismukes WD, Bradsher R, Girard W et al. (1986) Itraconazole therapy for blastomycosis and histoplasmosis. 26th Interscience Conference on antimicrobial agents and chemotherapy, abstract 798.
Philips JR, Jones S, Adamson JS et al. (1972) Long-term follow-up of 101 patients with blastomycosis. Am Rev Resp Dis 105:1006–1007.
Hawkins SS, Gregory DW, Alford RH (1981) Progressive disseminated histoplasmosis: favorable response to ketoconazole. Ann Int Med 95:446–449.
Drouhet E, DuPonte B (1983) Laboratory and clinical assessment of ketoconazole in deep seated mycoses. Am J Med 74 (S):30–47.
Slama TG (1983) Treatment of disseminated and progressive cavitary histoplasmosis with ketoconazole. Am J Med 74 (S):70–73.
Negroni R, Palmieri O, Koren K et al. (1987) Oral treatment of paracoccidioidomycosis and histoplasmosis with itraconazole in humans. Rev Inf Dis 9 (S):S47–S50.
Reddy P, Gorelick DF, Brasher CA et al. (1970) Progressive disseminated histoplasmosis as seen in adults. Am J Med 48:629–636.
Parker JD, Sarosi GA, Doto IL, Bailey RE, Tosh FE (1970) Treatment of chronic pulmonary histoplasmosis: a National Communicable Disease Control cooperative mycoses study. N Engl J Med 283:225–229.
Wheat LJ, Small CB (1984) Disseminated histoplasmosis in the acquired immune deficiency syndrome. Arch Int Med 144:2147–2149.
Graybill JR, Lundberg D, Donovan W et al. (1980) Treatment of coccidioidomycosis with ketoconazole: clinical and laboratory studies of 18 patients. Rev Inf Dis 2:661–673.
DeFelice R, Galgiani JN, Campbell SC et al. (1982) Ketoconazole therapy of nonprimary coccidioidomycosis: evaluation of 60 patients during three years of study. Am J Med 72:681–687.
Stevens DA, Stiller RL, Williams PL (1983) Experience with ketoconazole in three major manifestations of progressive coccidioidomycosis. Am J Med 74(S):58–63.
Graybill JR, Galgiani J, Stevens D et al. (1986) Progress in treatment of systemic mycoses: recent trials of the Mycoses Study Group. In Iwata K, Vanden Bossche H (eds) in vitro and in vivo evaluation of antifungal agents. Elsevier, Amsterdam, pp 247–256.
Graybill JR, Stevens DA, Galgiani JN et al. (1986) Itraconazole therapy of coccidioidomycosis. Twenty Sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, Abstract 788.
Restrepo A, Gomez I, Cano L et al. (1983) Treatment of paracoccidioidomycosis with ketoconazole: a three-year experience. Am J Med 74(S):48–52.
Restrepo A, Gomez I, Cano L et al. (1983) Post-therapy status of paracoccidioidomycosis treated with ketoconazole. Am J Med 74(S):53–57.
Restrepo A, Gomez I, Robledo J et al. (1987) Itraconazole in the treatment of paracoccidioidomycosis: a preliminary report. Rev Inf Dis 9(S):S51–S56.
Zuger A, Louie E, Holzman S et al. (1986) Cryptococcal disease in patients with the acquired immunodeficiency syndrome. Ann Int Med 104:234–240.
Kovacs JA, Kovacs AA, Polis M et al. (1985) Cryptococcosis in the acquired immunodeficiency syndrome. Ann Int Med 103:533–538.
Gershon SL, Talbot GH, Hurwitz S et al. (1985) Discriminant scorecard for diagnosis of invasive pulmonary aspergillosis in patients with acute leukemia. Am J Med 79:57–64.
Parfrey NA (1986) Improved diagnosis and prognosis of mucormycosis. Medicine 65:113–123.
Berkowitz ID, Robboy SJ, Karchmer AW et al. (1979) Torulopsis glabrata fungemia — a clinicopathologic study. Medicine 58:430–440.
Hoy J, Hsu K-C, Rolston K et al. (1986) Trichosporon beigelii: a review. Rev Inf Dis 8:959–967.
Jameson B, Carter RL, Watson JG et al. (1981) An unexpected fungal infection in a patient with leukemia. J Clin Pathol 34:267–270.
Meunier-Carpentier F, Cruciani M, Klastersky J (1983) Oral prophylaxis with miconazole or ketoconazole of invasive fungal disease in neutropenic cancer patients. Eur J Clin Oncol 19:43–48.
Jones PG, Kaufman C, McAuliffe LS et al. (1984) Efficacy of ketoconazole vs nystatin in prevention of fungal infections in neutropenic patients. Arch Int Med 144:549–551.
Hann IM, Corringham R, Keaney M et al. (1982) Ketoconazole versus nystatin plus amphotericin B for fungal prophylaxis in severely immunocompromised patients. Lancet I:826–829.
Meunier-Carpentier F (1984) Chemoprophylaxis of fungal infections. Am J Med 76:652–656.
Tricot G, Joosten E, Boogaerts MA et al. (1987) Ketoconazole vs itraconazole for antifungal prophylaxis in patients with severe granulocytopenia: preliminary results, of two nonrandomized studies. Rev Inf Dis 9(S):S94–S99.
Pizzo PA, Robichaud KJ, Gill FA et al. (1982) Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med 72:101–111.
Meunier-Carpentier F, Kiehn T, Armstrong D (1981) Fungemia in the immunocompromised host: changing patterns, antigenemia, high mortality. Am J Med 71:363–370.
Horn R, Wong B, Kiehn T (1985) Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. Rev Inf Dis 7:646–655.
Fisher BD, Armstrong D, Yu B, Gold JWM (1981) Invasive aspergillosis: progress in early diagnosis and treatment. Am J Med 71:571–577.
Burch PA, Karp JE, Merz WG et al. (1986) Favorable outcome of invasive aspergillosis (IA) in adult acute leukemia. Twenty-sixth Interscience Conference on Antimicrobial Agents and Chemotherapy, 1986, abstract 782.
Lopez-Berestein G, Fainstein V, Hopfer R et al. (1985) Liposomal amphotericin B for the treatment of systemic fungal infections in patients with cancer: a preliminary study. J Inf Dis 151:704–710.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Solano Aquilar, E. et al. (1988). Systemic Mycosis. In: Orfanos, C.E., Stadler, R., Gollnick, H. (eds) Dermatology in Five Continents. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-83360-1_48
Download citation
DOI: https://doi.org/10.1007/978-3-642-83360-1_48
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-83362-5
Online ISBN: 978-3-642-83360-1
eBook Packages: Springer Book Archive